GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhongzhi Pharmaceutical Holdings Ltd (HKSE:03737) » Definitions » Shareholder Yield %

Zhongzhi Pharmaceutical Holdings (HKSE:03737) Shareholder Yield % : -9.12% (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Zhongzhi Pharmaceutical Holdings Shareholder Yield %?

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return. As of today, Zhongzhi Pharmaceutical Holdings's Shareholder Yield % was -9.12%.


Zhongzhi Pharmaceutical Holdings Shareholder Yield % Historical Data

The historical data trend for Zhongzhi Pharmaceutical Holdings's Shareholder Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongzhi Pharmaceutical Holdings Shareholder Yield % Chart

Zhongzhi Pharmaceutical Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shareholder Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.40 -9.20 2.60 6.78 -8.20

Zhongzhi Pharmaceutical Holdings Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Shareholder Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.60 2.71 6.78 1.24 -8.20

Competitive Comparison of Zhongzhi Pharmaceutical Holdings's Shareholder Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Zhongzhi Pharmaceutical Holdings's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhongzhi Pharmaceutical Holdings's Shareholder Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhongzhi Pharmaceutical Holdings's Shareholder Yield % distribution charts can be found below:

* The bar in red indicates where Zhongzhi Pharmaceutical Holdings's Shareholder Yield % falls into.


;
;

Zhongzhi Pharmaceutical Holdings Shareholder Yield % Calculation

Zhongzhi Pharmaceutical Holdings's Shareholder Yield % for the quarter that ended in Dec. 2024 is calculated as:

Shareholder Yield %=Dividend Yield %+Buyback Yield %+Net Debt Paydown Yield %
=3.03 %+0.46 %+-11.69 %
=-8.2 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.


Zhongzhi Pharmaceutical Holdings  (HKSE:03737) Shareholder Yield % Explanation

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."

Shareholder Yield % is calculated by three components: Dividend Yield %, Buyback Yield %, and Net Debt Paydown Yield %.

Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.

Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.


Zhongzhi Pharmaceutical Holdings Shareholder Yield % Related Terms

Thank you for viewing the detailed overview of Zhongzhi Pharmaceutical Holdings's Shareholder Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhongzhi Pharmaceutical Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 3 Kangtai Road South, Torch Development Zone, Guangdong Province, Zhongshan, CHN
Zhongzhi Pharmaceutical Holdings Ltd is engaged in the business of manufacturing and selling pharmaceutical products. The group's operations can be divided into three segments, namely Pharmaceutical manufacturing, Operation of chain pharmacies, and Operation of online pharmacies in Zhongshan in the Guangdong province, the PRC. In the Pharmaceutical manufacturing segment, the company is engaged in the research and development, manufacturing and sale of Chinese patent medicines. In the Operation of chain pharmacies segment, the firm operates chain pharmacies in Zhongshan under the brand Zeus for the sale of pharmaceutical products. The Operation of online pharmacies segment sells medicines online. It derives a majority of its revenue from the PRC.
Executives
Jiang Li Xia 2202 Interest of your spouse
Lai Zhi Tian 2201 Interest of corporation controlled by you
Crystal Talent Investment Group Limited 2101 Beneficial owner
Cheng Jin Le 2201 Interest of corporation controlled by you
Advance Keypath Global Investment Limited 2101 Beneficial owner
Novich Positioning Investment (cayman) Limited 2201 Interest of corporation controlled by you
Novich Positioning Investment Limited Partnership 2101 Beneficial owner

Zhongzhi Pharmaceutical Holdings Headlines

No Headlines